Greater Occipital Nerve (GON) Block Effectivity in the Treatment of Chronic Migraine: 6 Months Follow up

NCT02578719 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Local Drug Authority didn't give permission to start.

Conditions

Migraine Disorders

Interventions

DRUG: bupivacaine
DRUG: saline

Sponsor

Bozok University